Aziyo Biologics Inc expected to post a loss of 63 cents a share - Earnings Preview

Elutia

28/02/2023 24:24

* Aziyo Biologics Inc  AZYO.OQ   AZYO.O  is expected to show
a
rise in quarterly revenue when it reports  results on March 1
(estimated). 
    * The Silver Spring Maryland-based  company is expected to
report 
a 14.9% increase in revenue to $12.483 million from $10.86
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Aziyo Biologics Inc
is
for a loss of 63 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Aziyo
Biologics
Inc is $13​, above​ its last closing price of $4.16. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.65       -0.66      -0.73     Missed  -9.9
 Jun. 30 2022  -0.55       -0.56      -0.69     Missed  -23.8
 Mar. 31 2022  -0.62       -0.62      -0.60     Beat    3.7​
 Dec. 31 2021  -0.68       -0.68      -0.82     Missed  -20.1
 ​​Sep.        -0.62       -0.62      -0.81     Missed  -30.1
 30 2021                                                
 Jun. 30 2021  -0.55       -0.53      -0.58     Missed  -8.9​
 Mar. 31 2021  -0.57       -0.57      -0.50     Beat    11.8
 Dec. 31 2020  -0.50       -0.50      -0.57     Missed  -13.7
 This summary was machine generated February 28 at 00:24 GMT. 
All figures in US dollars  unless otherwise stated